Concepedia

Frank van Leth

FV

Statistics

Publications

86

Citations

4.7K

H-Index

33

Active since

2001

Affiliations

University of Amsterdam(Current)

Amsterdam UMC Location University of Amsterdam

Amsterdam Institute for Global Health and Development

TuBerculosis Vaccine Initiative

Ministry of Health and Social Welfare

Frank van Leth is an author at University of Amsterdam specializing in public health, tuberculosis epidemiology, and tuberculosis control.

ORCID

Publications per year

2001–2025

86

Publications

86

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

, , +12

Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

Éric Fontas, Frank van Leth, Caroline Sabin et al. · The Journal of Infectious Diseases · 2004 · 336 citations · Full text

, , +17

Nevirapine and Efavirenz Elicit Different Changes in Lipid Profiles in Antiretroviral- Therapy-Naive Patients Infected with HIV-1

Frank van Leth, Prahpan Phanuphak, Erik S.G. Stroes et al. · PLoS Medicine · 2004 · 276 citations · Full text

, , +16

Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study

Martina Sester, Frank van Leth, Judith Bruchfeld et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 263 citations · Full text

, , +17

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

Marc van der Valk, John J.P. Kastelein, Robert L. Murphy et al. · AIDS · 2001 · 255 citations

, , +17

1–5 of 86